Literature DB >> 14517700

The -1030/-862-linked TNF promoter single-nucleotide polymorphisms are associated with the inability to control HIV-1 viremia.

Julio C Delgado1, Jessica Y Leung, Andres Baena, Olga P Clavijo, Eric Vittinghoff, Susan Buchbinder, Steven Wolinsky, Marilynn Addo, Bruce D Walker, Edmond J Yunis, Anne E Goldfeld.   

Abstract

Control of HIV-1 viremia and progression to AIDS has been associated with specific HLA genes. The tumor necrosis factor ( TNF) and the non-classical major histocompatibility (MHC) class I chain-related A ( MICA) genes are located in the genomic segment between the HLA class I and II genes and variants of both genes have been identified. We thus analyzed TNF promoter and MICA variants in a well-characterized group of HIV-1 infected individuals with different abilities to control HIV-1 viremia. In our cohort, the -1030/-862-linked TNF promoter single-nucleotide polymorphisms (SNPs), but not MICA variants, are significantly associated with lack of control of HIV-1 viremia ( P=0.03). This association is independent of those HLA-B35 alleles associated with HIV-1 disease progression with which the -862 TNF SNP has previously been independently associated. Thus, non-randomly associated genes near the TNF locus are likely involved in control of HIV-1 viremia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14517700     DOI: 10.1007/s00251-003-0604-7

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  24 in total

1.  Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product.

Authors:  A G Wilson; F S di Giovine; A I Blakemore; G W Duff
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

2.  A new TNFA promoter allele identified in South American Blacks.

Authors:  P A Zimmerman; R H Guderian; T B Nutman
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

3.  TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry.

Authors:  A Baena; J Y Leung; A D Sullivan; I Landires; N Vasquez-Luna; J Quiñones-Berrocal; P A Fraser; G P Uko; J C Delgado; O P Clavijo; S Thim; S R Meshnick; T Nyirenda; E J Yunis; A E Goldfeld
Journal:  Genes Immun       Date:  2002-12       Impact factor: 2.676

4.  The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth.

Authors:  B K Chen; M B Feinberg; D Baltimore
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter.

Authors:  J V Falvo; A M Uglialoro; B M Brinkman; M Merika; B S Parekh; E Y Tsai; H C King; A D Morielli; E G Peralta; T Maniatis; D Thanos; A E Goldfeld
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

Authors:  M Carrington; G W Nelson; M P Martin; T Kissner; D Vlahov; J J Goedert; R Kaslow; S Buchbinder; K Hoots; S J O'Brien
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

7.  Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.

Authors:  X Gao; G W Nelson; P Karacki; M P Martin; J Phair; R Kaslow; J J Goedert; S Buchbinder; K Hoots; D Vlahov; S J O'Brien; M Carrington
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

8.  Cloning and genomic characterization of LST1: a new gene in the human TNF region.

Authors:  I Holzinger; A de Baey; G Messer; G Kick; H Zwierzina; E H Weiss
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter.

Authors:  A M Uglialoro; D Turbay; P A Pesavento; J C Delgado; F E McKenzie; J G Gribben; D Hartl; E J Yunis; A E Goldfeld
Journal:  Tissue Antigens       Date:  1998-10

10.  Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese.

Authors:  T Higuchi; N Seki; S Kamizono; A Yamada; A Kimura; H Kato; K Itoh
Journal:  Tissue Antigens       Date:  1998-06
View more
  5 in total

1.  Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.

Authors:  Sergi Veloso; Montserrat Olona; Felipe García; Pere Domingo; Carlos Alonso-Villaverde; Montserrat Broch; Joaquim Peraire; Consuelo Viladés; Montserrat Plana; Enric Pedrol; Miguel López-Dupla; Carmen Aguilar; Mar Gutiérrez; Agathe Leon; Mariona Tasias; Josep Ma Gatell; Cristóbal Richart; Francesc Vidal
Journal:  BMC Med Genet       Date:  2010-04-26       Impact factor: 2.103

2.  Natural Killer Cell Receptor NKG2A/HLA-E Interaction Dependent Differential Thymopoiesis of Hematopoietic Progenitor Cells Influences the Outcome of HIV Infection.

Authors:  Edmond J Yunis; Viviana Romero; Felipe Diaz-Giffero; Joaquin Zuñiga; Prasad Koka
Journal:  J Stem Cells       Date:  2007

3.  Primate TNF promoters reveal markers of phylogeny and evolution of innate immunity.

Authors:  Andres Baena; Alan R Mootnick; James V Falvo; Alla V Tsytskova; Filipa Ligeiro; Ousmane M Diop; Claudia Brieva; Pascal Gagneux; Stephen J O'Brien; Oliver A Ryder; Anne E Goldfeld
Journal:  PLoS One       Date:  2007-07-18       Impact factor: 3.240

4.  High producer haplotype (CAG) of -863C/A, -308G/A and -238G/A polymorphisms in the promoter region of TNF-α gene associate with enhanced apoptosis of lymphocytes in HIV-1 subtype C infected individuals from North India.

Authors:  Sukhvinder Singh; Aman Sharma; Sunil K Arora
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

5.  Identification of functional tumor necrosis factor-alpha promoter variants associated with Helicobacter pylori infection in the Sudanese population: Computational approach.

Authors:  Abeer Babiker Idris; Alaa B Idris; Manal A Gumaa; Mohammed Babiker Idris; Amanda Elgoraish; Mohamed Mansour; Dalia Allam; Bashir Mo Arbab; Nazar Beirag; El-Amin M Ibrahim; Mohamed A Hassan
Journal:  World J Gastroenterol       Date:  2022-01-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.